Protocol Design Services & Products
-
The North American Advantage
8/8/2024
With more than 80% of Avance Clinical’s biotech clients located in North America, the region has played a significant role in the almost three decades of the company’s growth.
-
Medical Writing: A Collaborative Approach
7/31/2024
Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.
-
Biostatistics: End-To-End Management
7/31/2024
Discover how a team of biostatistics and pharmacokinetics experts can offer specialized guidance for clinical trial design and analysis.
-
Clinical Operations And Project Management
7/31/2024
Consider the benefits of an integrated operations and project management approach across all phases and regions.
-
Clinical Development
7/24/2024
Advisory and execution services to efficiently advance new drugs and devices to market.
-
Your Top Partner For Ophthalmic Drug Development
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Pharmacovigilance Solutions
3/20/2024
Free your safety and clinical teams to focus on what matters most.
-
Develop And Implement Effective Brand Strategies
12/6/2023
Insights to guide your decision-making, from strategic planning to launch optimization and beyond.
-
Enhance Data Quality, Increase Efficiency, And Drive Innovation
12/6/2023
Technology to meet the demands of today's clinical research and drug safety, ensuring innovation is at the forefront in clinical trial execution.
-
Strategic Support for Preclinical And Early Phase Planning
12/6/2023
Data, tools, and guidance to identify and prioritize opportunities and optimize clinical trial planning.